期刊文献+

三色混合荧光HPV假病毒中和检测系统的建立及评价 被引量:4

Establishment and evaluation of a triple-color human papillomavirus pseudovirion neutralization assay
原文传递
导出
摘要 目的建立三色混合荧光HPV假病毒中和检测系统,并评价其在检测HPV九价疫苗免疫血清免疫原性的应用。方法分别选取红色、绿色和蓝色荧光蛋白的质粒N31-MCHREEY、N31-EGFP和N31-mTagBFP构建HPV6/11/16/18/31/33/45/52/58假病毒,利用双抗夹心法和病毒半数组织培养感染剂量法检测HPV假病毒浓度和感染滴度;利用单色荧光与三色混合荧光HPV16/33/45假病毒,检测HPV九价疫苗免疫小鼠血清的中和滴度,以验证三色混合荧光HPV假病毒系统的准确性;采用单色荧光和三色混合荧光HPV6/11/16/18/31/33/45/52/58假病毒系统检测HPV九价疫苗免疫食蟹猴血清的中和滴度,判断其是否可应用于HPV九价疫苗免疫血清的免疫原性检测。结果含有绿色、红色和蓝色荧光质粒的HPV16型假病毒的浓度为5~6 μg/ml,HPV6/11/18/31/33/45/52/58的三色混合荧光假病毒浓度为1~3 μg/ml。获得了分别含有EGFP、Mcherry和mTagBFP报告基因的9个型别的HPV假病毒,且满足中和检测需要;9个型别单色荧光HPV假病毒的滴度值均在1×104~1×105之间,即它们具有相似的感染滴度。检测HPV九价疫苗免疫的小鼠血清时,单色荧光与三色混合荧光HPV16/33/45假病毒系统所得中和滴度值差异均无统计学意义(P值均〉0.05);检测HPV九价疫苗免疫的食蟹猴血清时,单色荧光与三色混合荧光A、B和C组HPV6/11/16/18/31/33/45/52/58假病毒所得中和滴度值差异均无统计学意义(P值均〉0.05)。结论成功地建立了三色混合荧光HPV假病毒中和检测系统;验证其与单色荧光HPV假病毒系统具有一致性;证实其可应用于检测HPV九价疫苗免疫血清的免疫原性检测中。 ObjectiveTo establish a triple-color pseudovirion-based neutralization assay (PBNA) and evaluate its capability of detecting immunogenicity of the sera generated by the immunization of HPV 9-valent vaccine.MethodsHPV pseudovirus (PsVs) 6/11/16/18/31/33/45/52/58 with the encapsidated fluorescence expressing red fluorescent plasmid N31-MCHREEY, green fluorescent N31-EGFP or blue fluorescent N31-mTagBFP were generated. The concentration of HPV PsVs and the infection titers of HPV PsVs were detected by double-antibody sandwich ELISA and TCID50, respectively. The single- and triple color HPV 16/33/45 PsVs were used to detect the neutralization titers of mice sera immunized with HPV 9-valent vaccine and confirmed the accuracy and specificity of the triple-color PBNAs. Then, the single- and triple color HPV 6/11/18/31/33/45/52/58 PsVs were employed to detect the neutralization titers of cynomolgus macaques sera immunized with HPV 9-valent vaccine and determined whether the triple-color PBNAs could be applied to evaluate the immunogenicity of the sera generated by the immunization of HPV9-valent vaccine.ResultsThe concentration of HPV16 PsVs encapsulating green, red or blue fluorescent plasmid was 5.0 to 6.0 μg/ml and HPV6/11/18/31/33/45/52/59 triple-color HPV PsVs was about 1.0 to 3.0 μg/ml. 9 types HPV PsVs containing EGFP, Mcherry or mTagBFP reporter plasmid were obtained and the concentration can meet the need of neutralization detection. 9 types single-color fluorescent HPV PsVs had similar infectivity against 293FT cells with the infection titer values between 1×104 and 1×105. The results of PBNAs showed that there was no significant difference in the anti-HPV neutralization titers of mice sera induced by HPV 9-valent vaccine between single-color and triple-color HPV16/33/45 PsVs (P〉0.05). Similarly, there was also no significant difference in the anti-HPV neutralization titers of cynomolgus macaques sera induced by HPV 9-valent vaccine between single-color and triple-color HPV6/11/18/31/33/45/52/58 PsVs (P〉0.05).ConclusionWe successfully established the triple-color PBNAs and verified the accuracy and specificity of triple-color PBNAs consistent with single-color PBNAs. The triple-color PBNAs can be applied to evaluate the immunogenicity of HPV 9-valent vaccine's immune serum.
作者 魏双萍 范飞 陈洁 柳欣林 杨与柔 王致萍 宋硕 李智海 魏旻希 王大宁 李少伟 夏宁邵 Wei Shuangping;Fan Fei;Chen Jie;Liu Xinlin;Yang Yurou;Wang Zhiping;Song Shuo;Li Zhihai;Wei Minxi;Wang Darting;Li Shaowei;Xia Ningshao(National Institute of Diagnostics and Vaccine Development of Infectious Diseases,State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics,School of Life Sciences,Xiamen University,Xiamen 361102,China)
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2018年第10期1039-1044,共6页 Chinese Journal of Preventive Medicine
基金 国家自然科学基金(31670935)
关键词 疫苗 中和试验 免疫血清 人乳头瘤病毒 三色荧光假病毒 Vaccine Neutralization tests Immune sera Human papillomavirus HPV triple-color pseudovirus
  • 相关文献

参考文献7

二级参考文献69

  • 1卢五迅,程通,李少伟,潘晖榕,沈文通,陈毅歆,张涛,郑舟,张军,夏宁邵.人乳头瘤病毒16型假病毒中和实验的建立和初步应用[J].生物工程学报,2006,22(6):990-995. 被引量:13
  • 2Finnen R L, Erickson K D, Chen X S, et al. Interactions between papillomavirus L1 and L2 capsid proteins[J]. J Virol, 2003,77(8) :4818-4826.
  • 3Schiller J T, Davies P. Delivering on the promise: HPV vaccines and cervical cancer[J]. Nat Rev Microbiol,2004, 2(4):343--347.
  • 4Koutsky L A,Galloway D A, Holmes K K. Epidemiology of genital human papillomavirus infection[J]. Epidemiol Rev, 1988,10 : 122-- 163.
  • 5Bedell M A,Hudson J B,Golub T R,et al. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation[J]. J Virol, 1991,65 (5) : 2254 -- 2260.
  • 6Pastrana D V, Buck C B, Pang Y Y, et al. Reactivity of human sera in a sensitive, high-throughput pseudovirus- based papillomavirus neutralization assay for HPV16 and HPV18[J]. Virol,2004,321 (2):205--216.
  • 7Pyeon D, Lambert P F, Ahlquist P. Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation[J]. Proc Natl Acad Sci USA,2005,102(26) :9311--9316.
  • 8Buck C B, Thompson C D, Pang Y Y, et al. Maturation of papillomavirus eapsids [J ]. J Virol, 2005,79 (5) : 2839 - 2846.
  • 9Buck C B,Pastrana D V, Lowy D R,et al. Efficient intracellular assembly of papillomaviral vectors[J]. J Virol,2004,78(2):751--757.
  • 10Holmgren S C, Patterson N A, Ozbun M A, et al. The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle [J]. J Virol, 2005,79 (7) : 3938- 3948.

共引文献95

同被引文献23

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部